|T-cell reconstitution after thymus xenotransplantation induces hair depigmentation and loss.|
|Jump to Full Text|
|PMID: 23303453 Owner: NLM Status: MEDLINE|
|Here we present a mouse model for T-cell targeting of hair follicles, linking the pathogenesis of alopecia to that of depigmentation disorders. Clinically, thymus transplantation has been successfully used to treat T-cell immunodeficiency in congenital athymia, but is associated with autoimmunity. We established a mouse model of thymus transplantation by subcutaneously implanting human thymus tissue into athymic C57BL/6 nude mice. These xenografts supported mouse T-cell development. Surprisingly, we did not detect multiorgan autoimmune disease. However, in all transplanted mice, we noted a striking depigmentation and loss of hair follicles. Transfer of T cells from transplanted nudes to syngeneic black-coated RAG(-/-) recipients caused progressive, persistent coat-hair whitening, which preceded patchy hair loss in depigmented areas. Further transfer experiments revealed that these phenomena could be induced by CD4+ T cells alone. Immunofluorescent analysis suggested that Trp2+ melanocyte-lineage cells were decreased in depigmented hair follicles, and pathogenic T cells upregulated activation markers when exposed to C57BL/6 melanocytes in vitro, suggesting that these T cells are not tolerant to self-melanocyte antigens. Our data raise interesting questions about the mechanisms underlying tissue-specific tolerance to skin antigens.|
|Anna L Furmanski; Ryan F L O'Shaughnessy; Jose Ignacio Saldana; Michael P Blundell; Adrian J Thrasher; Neil J Sebire; E Graham Davies; Tessa Crompton|
Related Documents :
|24129963 - Osteopontin has a crucial role in osteoclast-like multinucleated giant cell formation.
24223933 - Circulating cd4+cd161+ t lymphocytes are increased in seropositive arthralgia patients ...
6207243 - Human cytotoxic t cell clones directed against herpes simplex virus-infected cells. ii....
|Type: In Vitro; Journal Article; Research Support, Non-U.S. Gov't Date: 2013-01-10|
|Title: The Journal of investigative dermatology Volume: 133 ISSN: 1523-1747 ISO Abbreviation: J. Invest. Dermatol. Publication Date: 2013 May|
|Created Date: 2013-04-18 Completed Date: 2013-07-09 Revised Date: 2014-10-28|
Medline Journal Info:
|Nlm Unique ID: 0426720 Medline TA: J Invest Dermatol Country: United States|
|Languages: eng Pagination: 1221-30 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
Alopecia / pathology, physiopathology*
CD4-Positive T-Lymphocytes / pathology*, physiology
Disease Models, Animal
Hair Color / physiology*
Hair Follicle / pathology, physiology
Homeodomain Proteins / genetics
Melanocytes / pathology, physiology
Mice, Inbred C57BL
Pigmentation / physiology*
Thymus Gland / transplantation*
Up-Regulation / physiology
|090233//Wellcome Trust; BB/H005188/1//Biotechnology and Biological Sciences Research Council; BB/I026324/1//Biotechnology and Biological Sciences Research Council; G0900161//Medical Research Council; //Biotechnology and Biological Sciences Research Council; //Department of Health; //Medical Research Council; //Wellcome Trust|
|0/Homeodomain Proteins; 128559-51-3/RAG-1 protein|
Journal ID (nlm-ta): J Invest Dermatol
Journal ID (iso-abbrev): J. Invest. Dermatol
Publisher: Nature Publishing Group
Copyright © 2013 The Society for Investigative Dermatology, Inc
Received Day: 16 Month: 07 Year: 2012
Revision Received Day: 07 Month: 11 Year: 2012
Accepted Day: 13 Month: 11 Year: 2012
Print publication date: Month: 05 Year: 2013
Electronic publication date: Day: 10 Month: 01 Year: 2013
Volume: 133 Issue: 5
First Page: 1221 Last Page: 1230
PubMed Id: 23303453
Publisher Item Identifier: jid2012492
|T-Cell Reconstitution after Thymus Xenotransplantation Induces Hair Depigmentation and Loss Alternate Title:Thymic Xenotransplantation-Induced Skin Pathology|
|Anna L Furmanski1|
|Ryan F L O'Shaughnessy1|
|Jose Ignacio Saldana1|
|Michael P Blundell2|
|Adrian J Thrasher2|
|Neil J Sebire3|
|E Graham Davies24|
1Immunobiology Unit, Institute of Child Health, University College London, London, UK
2Molecular Immunology Unit, Wolfson Centre for Gene Therapy of Childhood Disease and Centre for Immunodeficiency, UCL Institute of Child Health, London, UK
3Department of Histopathology, Great Ormond Street Hospital, London, UK
4Department of Immunology, Great Ormond Street Hospital, London, UK
|*Immunobiology Unit, UCL Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK. E-mail: firstname.lastname@example.org
Alopecia is a disfiguring form of hair loss, which may be reversible, or irreversible, as in scarring alopecias. There are several subtypes of immune-mediated hair loss, ranging in severity from small isolated patches of reversible alopecia (alopecia areata) to extensive or total loss of body hair (alopecia totalis, AT; alopecia universalis), which in some cases is permanent (Lew et al., 2009). Disease is thought to occur when autoreactive T cells attack hair follicles, which are normally immune privileged (Gilhar et al., 1999, 2007). Follicular melanocytes are frequently damaged in early alopecia lesions (Tobin et al., 1990). Clinically, it has been noted that hair regrowth is often white, and that pigmented hairs may be preferentially targeted during alopecia (Gilhar et al., 2007). Autoimmune vitiligo in humans typically presents as patchy skin depigmentation resulting from a T-cell response against self-melanocytes (Ongenae et al., 2003). The etiology of autoimmune subtypes of vitiligo and alopecia is not fully understood, but is likely to involve the loss of tolerance to skin antigens.
Here we used the athymic nude mouse (Pantelouris, 1968; Nehls et al., 1994) as a recipient for human thymus grafts, to establish a model of thymus transplantation for studying tolerance induction and autoimmunity. Complete DiGeorge Syndrome, a rare, fatal congenital athymia, is treated by unmatched thymus transplantation, which reconstitutes naive T-cell output, although not to normal levels (Markert et al., 2007). Autoimmunity has been observed in one-third of thymus transplant recipients (Markert et al., 2007; Levy et al., 2012), presumably due to major histocompatibility complex (MHC) mismatching.
Here we show that de novo mouse T-cell development is induced by transplanting human thymus epithelium into T cell–deficient nude mice, and that autoimmunity, consistently and predominantly directed at hair follicles, resulted from the presence of this thymus graft. We characterize the cellular mechanisms underlying this skin-specific immune response after thymus xenotransplantation. We present an inducible mouse model for depigmentation and hair loss, and suggest that there are as yet uncharacterized mechanisms driving induction of tolerance to skin self-antigens.
To investigate mechanisms driving autoimmunity in vivo, we established a mouse model of thymus transplantation. We implanted fragments of fresh or cultured (Supplementary Table S1 online) human thymus subcutaneously into the scruff of nude mice, providing a thymic epithelial niche, which expressed non-self-MHC and species-inappropriate antigens. We used subcutaneous implantation because clinical transplantations are performed in the thigh fascia (Markert et al., 1997).
Nude mice lack conventional T cells because of congenital athymia. Other lymphocytes are present, including B cells, which are functionally limited by the lack of T-cell help (Mongini et al., 1981), natural killer (NK) cells, some NKT and γδ-T cells, and gut intra-epithelial lymphocytes (De Geus et al., 1990). Therefore, to screen blood for conventional T cells, we used a stringent gating strategy to remove B cells, CD3-expressing NK cells, or γδ-T cells/intra-epithelial lymphocytes, which may express CD8, and dendritic cells that may express CD4/CD8 (Figure 1a). Nude mice transplanted with human thymus tissue (Nu-Tp) accepted xenografts and displayed mature T cells in peripheral blood lymphocytes (PBL) 12 weeks post transplant (Figure 1a and b). These T cells were of mouse origin, staining only with anti-mouse antibodies. No T cells of human origin were detected in transplanted mice (Figure 1c), indicating that thymus-resident human T cells did not persist. Anti-mouse antibodies did not bind human lymphocytes (Figure 1d). Most transplanted mice showed variable but lower proportions of CD3+ cells than Wt/Nu immunocompetent control animals. Wt/Nu mice had on average 23.6%±5.7 CD3+ PBL, whereas Nu-Tp displayed 3.0%±1.9 at 8 weeks, 6.1%±0.7 at 12 weeks, and 8.5%±3.9 at 17 weeks post transplant. A small number of transplants did not graft, likely because of failed implantation, with <1% T cells in the PBL gate (Figure 1a and e, Supplementary Table S1 online).
Reconstitution of T-cell subsets showed different kinetics, with CD4+ cells appearing in PBL 2–4 weeks later than CD8+ cells (Figure 1f). Postmortem, we detected immature mouse T cells (CD4+CD8+CD3−) in disaggregated subcutaneous scruff tissue (Figure 1g), demonstrating that T-cell development occurred in Nu-Tp animals.
To confirm that resident nude bone marrow–derived precursors were the source of de novo T cells, we performed transplants into Nude-RAG2−/−IL2Rγ−/− mice, which lack a thymus and functional murine T precursors. As expected, these mice were unable to generate T cells after human thymus grafting (data not shown), remaining profoundly lymphopaenic.
C57BL/6 nude mice lack fur because of abortive hair growth, but are not strictly hairless. The presence of hair follicles, which produce hairs that are unable to fully penetrate the epidermis, give the skin a black color (Militzer, 2001). Striping is observed as these hairs progress through murine hair cycling, and sparse patches of short black hair are occasionally seen (Eaton, 1976). After appearance of PBL in Nu-Tp mice, we observed macroscopic changes in body coloration, where skin appeared smooth and pink compared with the gray/black striping of untransplanted control nude mice (Figure 2a). We noted sparse areas of white hair, particularly on the face (Figure 2a), which were ultimately lost. We only observed this in mice that developed T cells after thymus grafting (Supplementary Table S1 online). We performed 11 grafts using tissue from five independent human donors. Three of these transplants failed. Of the remaining mice, all eight nude recipients displayed this characteristic skin phenotype.
Postmortem skin from Nu-Tp mice was thin, liable to tear, and had lost its black/gray coloration (Figure 2b). Skin histology revealed hair follicle dystrophy and loss in Nu-Tp (Supplementary Figure S2 online, Figure 2c–f) compared with control nude samples (Supplementary Figure S2 online, Figure 2g–j). Hair follicle disruption was widespread in Nu-Tp skin, although we were able to identify occasional follicles in anagen (Figure 2c–f), most of which were not pigmented. Cellular infiltrates were seen around the hair follicles, frequently in the upper region (Figure 2c and d). We did not observe epidermal hyperplasia, cysts, trichogranulomas, fibrotic lesions or external rashes, scarring, scaling, ulceration/blistering, redness, swelling, or dermatitis (Sundberg et al., 2011) in Nu-Tp mice. Nu-Tp hypodermis was severely disrupted, in several cases showing almost total loss of hair follicles, sebaceous glands, and subcutaneous fat (Supplementary Figure S2 online). Occasionally, hair follicle remnants were observed, although we did not observe hair regrowth in any animal during our experiments (6 months post transplant). Histomorphometry revealed that Nu-Tp skin showed significantly fewer follicles than non-transplanted controls, and most remaining hairs observed in Nu-Tp samples were white (Figure 2k).
This phenotype occurred after de novo T-cell output, suggesting that depigmentation and hair loss were mediated by a T-cell response against hair follicles, resembling autoimmune alopecia. We therefore examined the lymphocyte composition of skin from transplanted animals, observing CD4hiCD3hi T cells in Nu-Tp skin (Figure 2l), which were largely absent in nude controls. Interestingly, the proportion of CD4+ cells in digests was higher in Nu-Tp than in immunocompetent wild-type (WT) mice, typically 6.7% of live cells compared with 2.4%, respectively. Increased proportions of CD3+ T cells suggested enhanced infiltration or expansion of CD4+ T cells in Nu-Tp mice. Transplanted mice showed lower proportions of PBL than control immunocompetent animals (Figure 1e), and low but detectable populations of T cells in the spleen (not shown). Therefore, the presence of skin-resident T cells in these animals is likely to be functionally significant.
Nude mice are widely used for xenotransplantation, accepting many grafts, including human tissues, with no reports of adverse “unconventional” host immune responses or pathological dermatological effects (Manning et al., 1973; Gershwin et al., 1977; Drago et al., 1979). Therefore, in our model, it seems likely that the human tissue provides a niche in which host murine T-cell precursors can develop. Mouse TCR can bind and be selected on human MHC (Kievits et al., 1987), and the development and thymic selection of mouse TCR on HLA can occur without a human coreceptor (Altmann et al., 1995). In this case, an MHC mismatch would exist between the T cells' specificity and the host tissues, which express “foreign” murine MHC molecules. A widespread autoimmune syndrome might therefore be expected. However, we noted no other pathology in Nu-Tp mice displaying hair loss. To formally rule out chronic inflammation and autoimmunity, we screened several solid organs. We saw no histological abnormalities in Nu-Tp specimens, indicating that species mismatch between thymus and host tissues did not provoke multiorgan autoimmune disease (Supplementary Figure S1 online).
Hair biology in nude mice is abnormal, and our observations may relate to an underlying defect in nude skin. To test this and investigate the mechanism of hair follicle targeting, we collected lymphocytes from Nu-Tp mice with/without alopecia and adoptively transferred them into black-coated lymphocyte-deficient C57BL/6 RAG−/− mice (Figure 3a, AT1). We detected CD4+ and CD8+ PBL in mice given Nu-Tp alopecia lymphocytes, indicating successful transfer. No T cells were seen in RAG−/− hosts receiving no cells, or cells from lymph node of control/non-alopecia nude mice (not shown). Remarkably, at 8 weeks post transfer, mice that received cells from Nu-Tp with alopecia developed a striking coat depigmentation, manifesting initially in a white dorsal stripe (Figure 3b). At 15 weeks post transfer, this depigmentation had spread (Figure 3c), and eventually white areas showed hair loss (Figure 3d and e). This experiment (Figure 3a) was repeated with independent human thymus, nude host, and RAG−/− recipients. The same results were seen, except that depigmentation began over the cranium and extended down the body (Figure 3f). Interestingly, our phenotype resembled vitiligo-like autoimmunity seen in mice with a transgenic TCR specific for Trp-1, a melanocyte antigen (Muranski et al., 2008).
We found T cells in skin from depigmented mice (Figure 3g), a greater proportion of which expressed CD4 and CD3 compared with WT controls. Significantly fewer intact follicles were observed in AT1 skin compared with WT animals (Supplementary Figure S2b online, Figure 3h). AT1 hair follicles appeared microscopically to lack pigment, even in sections from areas of black fur, suggesting an active process of depigmentation before hair loss.
Histological analysis of AT1 skin showed hair follicle dystrophy compared with control skin (Supplementary Figure S2b online). Depigmented hairs (Figure 4a–d), or hairs with little pigment compared with controls (Figure 4e–g), were seen. We noted occasional swarms of cells around follicles, particularly in the infundibular region of anagen follicles, and around the receding bulb of telogen hairs (Muller-Rover et al., 2001) (Figure 4a and d).
More infiltrating CD4+ cells were observed around follicles and in the dermis of Nu-Tp (Figure 4i) and AT1 (Figure 4j) skin than in control sections. CD8+ cells were present in skin from experimental animals, although at lower frequencies than CD4+ cells (Figure 4), suggesting that in our model CD4+ cells are active in skin.
To dissect the cellular mechanism and identify the reactive T-cell subset/s, we performed further adoptive transfer experiments (Figure 5a). Lymphocytes were collected from lymph node of AT1 experimental animals (mice in Figure 3b–e), and T cells were fractionated by fluorescence-activated cell sorting. CD3+CD4+, CD3+CD8+, and CD3+γδTCR+ cells were purified (>98% pure, Figure 5b) and transferred into new RAG−/− recipients. At 16 weeks post transfer, a patch of localized alopecia surrounded by downy white hairs was observed on the shoulder of an animal that had received CD4+ cells (Figure 5c). CD3+CD4+ T cells were identified in skin from this area (Figure 5d). Mice that received CD8+ and γδ-T cells were kept for 21 weeks post transfer, but did not show any skin phenotype (not shown). Thus, CD4+ cells in isolation can cause pathology.
Given the hair whitening, loss of follicles in Nu-Tp mice, and subsequent widespread depigmentation of furred mice in adoptive transfer experiments, we hypothesized that melanocytes were the target-cell population for T cell–mediated autoimmune attack. Supporting this, we observed decreased levels of Trp2 staining in Nu-Tp hair follicles compared with controls, suggesting that there are fewer melanocyte-lineage cells in Nu-Tp skin (Figure 6a). We therefore tested responsiveness of Nu-Tp T cells to murine melanocytes. Splenocytes (including host antigen-presenting cells) from Nu-Tp and WT mice were cultured with C57BL/6 melan-a cells, a transformed melanocyte cell line, which we irradiated to prevent rapid proliferation. The proportion of T cells in Nu-Tp splenocyte cultures was lower than WT, reflecting suboptimal T-cell reconstitution (Figure 1e). However, despite the low frequency of T cells, after 48 hours in culture, a higher proportion of CD4+ T cells from Nu-Tp spleen expressed the T-cell activation marker CD25, compared with WT splenocyte cultures, indicating that a larger proportion of T cells in the mixed culture were activated by the presence of melanocytes (Figure 6b). A higher proportion of T cells in melan-a+Nu-Tp spleen cocultures were of memory phenotype (CD44hiCD62Llo) compared with melan-a+WT spleen cultures (Figure 6c). The proportion of naive T cells (CD44loCD62L+) was low in the Nu-Tp culture, whereas naive T cells were observed in melan-a+WT spleen cocultures (Figure 6c).
Here we showed that subcutaneous grafting of T cell–deficient nude mice with human thymus fragments restored murine T-cell development, despite the absence of species-appropriate signals that might be required for grafting, vascularization and colonization of human tissue. We observed murine T cells in Nu-Tp blood for >6 months post transplant, suggesting that the graft continues to function, and/or that human MHC is not required to support peripheral T-cell survival. The proportion of T cells in blood and lymphoid organs was low, as observed after thymus allografting in other systems (Yan et al., 2003; Markert et al., 2007); thus, tissue mismatching may impair positive selection and peripheral T-cell homeostasis.
We did not observe multiorgan autoimmunity in the Nu-Tp mice, suggesting either that graft-educated cells were unreactive, low-affinity clones or that some degree of self-tolerance was induced, centrally or in peripheral tissues. We cannot exclude subclinical autoimmunity, but some transplanted mice were kept for over 35 weeks post transplant without visible non-dermatological disease. All transplanted animals developed an alopecia-like disorder, resulting in severe hair follicle disruption and hair loss, which was not due to companion barbering. This occurred irrespective of human thymus donor. In vitro assays indicated that unprimed T cells from Nu-Tp mice activated in response to syngeneic melanocytes, and transfer of pathogenic Nu-Tp T cells to black-coated animals, led to significant depigmentation and subsequent localized hair loss. We therefore propose that a proportion of graft-educated mouse antigen–intolerant T cells attack follicular melanocytes, causing depigmentation. Loss of melanocytes then compromises follicle integrity/stability, leading to hair loss. Further, targeting of melanocyte-lineage cells in the infundibular region may disrupt the bulge stem-cell niche, which could prevent hair regrowth. This requires future investigation, as follicles may remain dormant for some time. In addition, as we were able to identify some remaining follicles in nude mice (Nu5), follicular destruction was not necessarily complete or irreversible during the time frame of our experiments.
Spontaneous rodent models of alopecia and vitiligo are available, but incidence of disease is low and unpredictable (Lerner et al., 1986; Sun et al., 2008). The C3H/HeJ skin grafting mouse model has provided insight into the pathogenesis of murine alopecia areata (McElwee et al., 1998, 2002, 2005; Sun et al., 2008), but this elegant model requires appearance of initial disease and surgical expertise. Recently, models of hair follicle autoimmunity have been engineered by transgenic expression of melanocyte antigen-specific TCR (Lambe et al., 2006; Gregg et al., 2010; Alli et al., 2012; Harris et al., 2012). These sophisticated tools are valuable, but suffer the disadvantage that autoimmunity is driven by a non-physiological, single TCR specificity. Our model, either of thymus grafting to C57BL/6 nudes or transfer of Nu-Tp T cells to RAG−/− recipients, can be considered inducible and therefore useful for studying disease onset and kinetics. Indeed, we were able to observe the active disease process (Figure 4). In addition, our model will aid investigation of the etiology of autoimmunity, as it relies on the failure of self-tolerance during the development of the endogenous T-cell repertoire.
Our data support the established hypothesis that autoimmune hair loss and depigmentation are T cell–mediated and suggest that these disorders can share a common pathogenesis, as previously reported in mice (Nagai et al., 2006) and chickens (Smyth and McNeil, 1999). Although there are clinical reports of coincidence of alopecia areata and vitiligo (Dhar and Kanwar, 1994; Adams and Lucky, 1999; Tan et al., 2002; Yadav et al., 2009; Akay et al., 2010; Ramot et al., 2010), the link between the two diseases is controversial, with some studies finding no association (Majumder et al., 1993).
CD4+ and CD8+ T cells have been detected in skin from alopecia areata and vitiligo sufferers (Gilhar et al., 2007). In our model, transfer of purified CD4+ T cells alone caused depigmentation and hair loss in furred RAG−/− mice. This indicates that CD4+ cells can mediate disease in isolation, without B cells or CD8+ T cells. CD4+ T cells generally function to activate other immune cell types. We did not observe large-scale inflammation in the skin of Nu-Tp or adoptively transferred mice, or an increase in the proportion of macrophages or neutrophils in skin (not shown). Melanocytes can express MHC Class II (Lu et al., 2002) and process antigen for presentation to T cells (Le Poole et al., 1993). Therefore, CD4+ T cells may directly recognize antigens presented by melanocytes (Rivoltini et al., 1998). There are several reports of CD4+ T cells functioning atypically to act as cytotoxic effectors (Marshall and Swain, 2011). In the future, it will be important to investigate this in our model, to determine whether CD4+ cell depletion strategies or directed immunotherapy can ameliorate pathology.
The fact that skin was predominantly and consistently targeted by autoimmune T cells in our system suggests that there are specific requirements for induction of tolerance to skin antigens, and is consistent with the observation that skin is a frequent site of autoimmunity.
In summary, we demonstrate a link between hair loss and depigmentation and show that these disorders can be caused by CD4+ T cells, in the absence of other lymphocyte populations. This study therefore provides an inducible mouse model to investigate the etiology, induction, and pathology of T cell–driven hair-follicle disorders.
Tissue was obtained during elective cardiac surgery at Great Ormond Street Hospital, London, fragmented by dissection (1 mm3 explants), or cut into <1-mm-thick slices and cultured for 14 days (Markert et al., 2010) before fragmentation. This study was conducted with institutional ethical approval, with written informed consent, and according to the Declaration of Helsinki principles.
C57BL/6 (B6) WT/nude (B6.Cg-Foxn1nu/J heterozygotes) and RAG1−/− (B6.127S7-Rag1tm1Mom/J) mice were from Jackson Labs (Bar Harbour, ME). Animals were housed in individually ventilated cages and underwent procedures in sterile conditions under the UK Home Office regulations.
Xenografting: Human thymus tissue (<100 mg) was subcutaneously injected in phosphate-buffered saline into the scruff under light inhaled anesthetic.
Adoptive transfer: 5 × 105–5 × 106 lymphocytes were injected intravenously in 200 μl of phosphate-buffered saline. Mice were tail-bled at regular intervals.
Skin samples were collected from anatomically matched locations, minced with scissors, digested with Liberase (0.15 mg ml−1, Roche, Burgess Hill, UK) and DNAse (0.5 mg ml−1, Roche) for 30 minutes at 37 °C, and filtered to obtain a single-cell suspension.
Cells were stained with fluorochrome-conjugated antibody (eBiosciences, Hatfield, UK or BD Pharmingen, Oxford, UK) in phosphate-buffered saline+5% fetal calf serum+0.01% azide for 10 minutes at room temperature, and washed and analyzed by flow cytometry (instrument: FACScan, BD; software: Cell Quest, BD, and FlowJo, TreeStar, Ashland, OR).
Tissues were fixed in Bouin's solution, embedded in wax, sectioned, deparaffinized, and examined by hematoxylin and eosin staining. Unfixed frozen sections (7 μm) were stained with rat anti-mouse CD4 and CD8 antibodies (eBiosciences, UK), followed by Alexa-Fluor594 anti-rat antibody (Invitrogen, Paisley, UK). Deparaffinized wax sections (5 μm) were stained with goat-anti Trp2 (Santa Cruz, Insight Biotechnology, London, UK), anti-goat Biotin (Alpha Diagnostic Intl, Source BioScience Life Sciences, Nottingham, UK), and Alexa-Fluor555 Streptavidin (Invitrogen). Sections were viewed by light/fluorescence microscopy (Leica DMLB, Milton Keynes, UK); representative examples are shown.
C57BL/6-transformed melanocyte cell line, melan-a, was obtained from the Wellcome Trust Functional Genomics Cell Bank, St George's University, London. Melan-a cells were grown to 60% confluence (Sviderskaya et al., 1997) and irradiated (60 Gy, gamma-source). Splenocytes were cultured at a density of 1 × 106 per ml at a 1:1 ratio with irradiated melan-a or B6 control splenocytes for 48 hours, before analysis by flow cytometry.
Supplementary material is linked to the online version of the paper at http://www.nature.com/jid
We thank Rebecca West for assistance with histology. This study was funded by BBSRC, MRC, Wellcome Trust, GOSH Children's Charity, and the Royal Society. ALF is supported by GOSH/ICH Biomedical Research Centre, funded by the Department of Health's NIHR's Biomedical Research Centres scheme.
|MHC||major histocompatibility complex|
|PBL||peripheral blood lymphocytes|
The authors state no conflict of interest.
|Adams BB,Lucky AW. Year: 1999Colocalization of alopecia areata and vitiligoPediatr Dermatol1636436610571834|
|Akay BN,Bozkir M,Anadolu Y,et al. Year: 2010Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in TurkeyJ Eur Acad Dermatol Venereol241144115020202047|
|Alli R,Nguyen P,Boyd K,et al. Year: 2012A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalisJ Immunol18847748622116824|
|Altmann DM,Douek DC,Frater AJ,et al. Year: 1995The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4J Exp Med1818678757532684|
|De Geus B,Van den Enden M,Coolen C,et al. Year: 1990Phenotype of intraepithelial lymphocytes in euthymic and athymic mice: implications for differentiation of cells bearing a CD3-associated gamma delta T cell receptorEur J Immunol202912981968837|
|Dhar S,Kanwar AJ. Year: 1994Colocalization of vitiligo and alopecia areataPediatr Dermatol1185868170863|
|Drago JR,Gershwin ME,Maurer RE,et al. Year: 1979Immunobiology and therapeutic manipulation of heterotransplanted Nb rat prostate adenocarcinoma into congenitally athymic (nude) mice. I. Hormone dependency and histopathologyJ Natl Cancer Inst6210571066285279|
|Eaton GJ. Year: 1976Hair growth cycles and wave patterns in “nude” miceTransplantation22217222788248|
|Gershwin ME,Ikeda RM,Kawakami TG,et al. Year: 1977Immunobiology of heterotransplanted human tumors in nude miceJ Natl Cancer Inst5814551461857033|
|Gilhar A,Paus R,Kalish RS. Year: 2007Lymphocytes, neuropeptides, and genes involved in alopecia areataJ Clin Invest1172019202717671634|
|Gilhar A,Shalaginov R,Assy B,et al. Year: 1999Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID miceJ Investig Dermatol Symp Proc4207210|
|Gregg RK,Nichols L,Chen Y,et al. Year: 2010Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic miceJ Immunol1841909191720083666|
|Harris JE,Harris TH,Weninger W,et al. Year: 2012A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skinJ Invest Dermatol1321869187622297636|
|Kievits F,Ivanyi P,Krimpenfort P,et al. Year: 1987HLA-restricted recognition of viral antigens in HLA transgenic miceNature3294474492821399|
|Lambe T,Leung JC,Bouriez-Jones T,et al. Year: 2006CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactionsJ Immunol1773055306216920942|
|Le Poole IC,Mutis T,van den Wijngaard RM,et al. Year: 1993A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disordersJ Immunol151728472928258725|
|Lerner AB,Shiohara T,Boissy RE,et al. Year: 1986A mouse model for vitiligoJ Invest Dermatol872993043525691|
|Levy E,Neven B,Entz-Werle N. Year: 2012[Post-thymus transplant vitiligo in a child with Foxn1 deficiency]Ann Dermatol Venereol13946847122721479|
|Lew BL,Shin MK,Sim WY. Year: 2009Acute diffuse and total alopecia: a new subtype of alopecia areata with a favorable prognosisJ Am Acad Dermatol60859318992964|
|Lu Y,Zhu WY,Tan C,et al. Year: 2002Melanocytes are potential immunocompetent cells: evidence from recognition of immunological characteristics of cultured human melanocytesPigment Cell Res1545446012453188|
|Majumder PP,Nordlund JJ,Nath SK. Year: 1993Pattern of familial aggregation of vitiligoArch Dermatol1299949988352624|
|Manning DD,Reed ND,Shaffer CF. Year: 1973Maintenance of skin xenografts of widely divergent phylogenetic origin of congenitally athymic (nude) miceJ Exp Med1384884944578300|
|Markert ML,Devlin BH,Alexieff MJ,et al. Year: 2007Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplantsBlood1094539454717284531|
|Markert ML,Devlin BH,McCarthy EA. Year: 2010Thymus transplantationClin Immunol13523624620236866|
|Markert ML,Kostyu DD,Ward FE,et al. Year: 1997Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymusJ Immunol15899810058993022|
|Marshall NB,Swain SL. Year: 2011Cytotoxic CD4 T cells in antiviral immunityJ Biomed Biotechnol201195460222174559|
|McElwee KJ,Boggess D,King LE,et al. Year: 1998Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin graftsJ Invest Dermatol1117978039804341|
|McElwee KJ,Freyschmidt-Paul P,Hoffmann R,et al. Year: 2005Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(−) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse modelJ Invest Dermatol12494795715854035|
|McElwee KJ,Hoffmann R,Freyschmidt-Paul P,et al. Year: 2002Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cellsJ Invest Dermatol1191426143312485450|
|Militzer K. Year: 2001Hair growth pattern in nude miceCells Tissues Organs16828529411275695|
|Mongini PK,Stein KE,Paul WE. Year: 1981T cell regulation of IgG subclass antibody production in response to T-independent antigensJ Exp Med1531126969777|
|Muller-Rover S,Handjiski B,van der Veen C,et al. Year: 2001A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stagesJ Invest Dermatol11731511442744|
|Muranski P,Boni A,Antony PA,et al. Year: 2008Tumor-specific Th17-polarized cells eradicate large established melanomaBlood11236237318354038|
|Nagai H,Oniki S,Oka M,et al. Year: 2006Induction of cellular immunity against hair follicle melanocyte causes alopeciaArch Dermatol Res29813113416786344|
|Nehls M,Pfeifer D,Schorpp M,et al. Year: 1994New member of the winged-helix protein family disrupted in mouse and rat nude mutationsNature3721031077969402|
|Ongenae K,Van Geel N,Naeyaert JM. Year: 2003Evidence for an autoimmune pathogenesis of vitiligoPigment Cell Res169010012622785|
|Pantelouris EM. Year: 1968Absence of thymus in a mouse mutantNature2173703715639157|
|Ramot Y,Thomaidou E,Mali A,et al. Year: 2010An extraordinary colocalization of alopecia areata and vitiligoInt J Trichology210810921712899|
|Rivoltini L,Radrizzani M,Accornero P,et al. Year: 1998Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killingJ Immunol161122012309686582|
|Smyth JR,McNeil M. Year: 1999Alopecia areata and universalis in the Smyth chicken model for spontaneous autoimmune vitiligoJ Investig Dermatol Symp Proc4211215|
|Sun J,Silva KA,McElwee KJ,et al. Year: 2008The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and resultsExp Dermatol1779380518798913|
|Sundberg JP,Taylor D,Lorch G,et al. Year: 2011Primary follicular dystrophy with scarring dermatitis in C57BL/6 mouse substrains resembles central centrifugal cicatricial alopecia in humansVet Pathol4851352420861494|
|Sviderskaya EV,Bennett DC,Ho L,et al. Year: 1997Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequencesJ Invest Dermatol10830348980282|
|Tan E,Tay YK,Goh CL,et al. Year: 2002The pattern and profile of alopecia areata in Singapore—a study of 219 AsiansInt J Dermatol4174875312452996|
|Tobin DJ,Fenton DA,Kendall MD. Year: 1990Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areataJ Invest Dermatol948038072355182|
|Yadav S,Dogra S,Kaur I. Year: 2009An unusual anatomical colocalization of alopecia areata and vitiligo in a child, and improvement during treatment with topical prostaglandin E2Clin Exp Dermatol34e1010e101120055821|
|Yan Y,Devos T,Yu L,et al. Year: 2003Pathogenesis of autoimmunity after xenogeneic thymus transplantationJ Immunol1705936594612794120|
Previous Document: Xiamenmycin Attenuates Hypertrophic Scars by Suppressing Local Inflammation and the Effects of Mecha...
Next Document: Potent dual inhibitors of TORC1 and TORC2 complexes (KU-0063794 and KU-0068650) demonstrate in vitro...